Patrick Waters
Contact information
01865 227840
Patrick Waters
PhD
Senior Postdoctoral Research Scientist
My research focuses on antibody mediated central nervous system diseases. I am interested in the discovery of new antibody targets, the optimisation of assays to detect antibodies in patients serum and CSF, and understanding the mechanism through which the antibodies cause disease.
Research groups
Websites
-
NHS Specialised Services for Neuromyelitis optica
NHS Specialised Services for Neuromyelitis optica
-
Guthy-Jackson NMO Website
Guthy-Jackson NMO Website
-
Eugene Devic European Network
EDEN Project
-
Associate Faculty Member of F1000
F1000
Key publications
-
Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes.
Journal article
Carvajal-González A. et al, (2014), Brain, 137, 2178 - 2192
-
Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 and Myelin-Oligodendrocyte Glycoprotein Antibodies A Comparative Study
Journal article
Kitley J. et al, (2014), Jama neurology, 71, 276 - 283
-
Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays.
Journal article
Waters PJ. et al, (2012), Neurology, 78, 665 - 671
-
N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes.
Journal article
Irani SR. et al, (2010), Brain, 133, 1655 - 1667
-
Progressive encephalomyelitis, rigidity, and myoclonus: a novel glycine receptor antibody.
Journal article
Hutchinson M. et al, (2008), Neurology, 71, 1291 - 1292
Recent publications
-
Chronic relapsing inflammatory optic neuropathy (CRION): a manifestation of myelin oligodendrocyte glycoprotein antibodies.
Journal article
Lee H-J. et al, (2018), J neuroinflammation, 15
-
Antiglycine receptor antibody related disease: a case series and literature review.
Journal article
Swayne A. et al, (2018), Eur j neurol, 25, 1290 - 1298
-
Association of Leucine-Rich Glioma Inactivated Protein 1, Contactin-Associated Protein 2, and Contactin 2 Antibodies With Clinical Features and Patient-Reported Pain in Acquired Neuromyotonia.
Journal article
Vincent A. et al, (2018), Jama neurol
-
Glutamate receptor δ2 serum antibodies in pediatric opsoclonus myoclonus ataxia syndrome.
Journal article
Berridge G. et al, (2018), Neurology, 91, e714 - e723
-
Neuromyotonia in thymoma-associated myasthenia gravis: a clinico-serological study
Conference paper
Gastaldi M. et al, (2018), European journal of neurology, 25, 351 - 351